PLoS ONE (Jan 2023)

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

  • Konstantinos Rounis,
  • Dimitrios Makrakis,
  • Chara Papadaki,
  • Alexia Monastirioti,
  • Lambros Vamvakas,
  • Konstantinos Kalbakis,
  • Krystallia Gourlia,
  • Iordanis Xanthopoulos,
  • Ioannis Tsamardinos,
  • Dimitrios Mavroudis,
  • Sofia Agelaki

DOI
https://doi.org/10.1371/journal.pone.0294382
Journal volume & issue
Vol. 18, no. 11
p. e0294382

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0252537.].